Explore

Innovations

                                        
                                    Published
                            
                Healthcare & Pharmaceuticals
            
Gene Therapy For CF (Phase II)
                First line gene therapy for cystic fibrosis;
Safe repeat administration using nebuliser;
Phase IIb randomised clinical trial complete;
Orphan Drug Designation secured in US and EU
            
By
                            Imperial Innovations
                        
Reference Number  
                00911
            
Last Update  
                 Nov 15, 2021
            
                                    Published
                            
                Medical
            
Gene therapy for MND
                To deliver genes directly to motor neurons from a minimally invasive, peripheral injection site.
            
By
                            Imperial Innovations
                        
Reference Number  
                00117
            
Last Update  
                 Nov 15, 2021
            
Do you have an innovative technology, product or service?
            Add your solution to the world’s most advanced open innovation platform and get seen by global corporations seeking new solutions – all free of charge.